CA2229515A1 - Expression d'une proteine de coque de spumavirus - Google Patents

Expression d'une proteine de coque de spumavirus Download PDF

Info

Publication number: CA2229515A1
Authority: CA; Canada
Prior art keywords: protein; envelope; construct; expression; hfv
Prior art date: 1997-03-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2229515

Other languages

English (en)

Inventor

Axel Rethwilm

Dirk Lindemann

Arend Jan Winter

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Transgene SA

Original Assignee

Transgene SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-13

Filing date

1998-03-13

Publication date

1998-09-13

1997-03-13 Priority claimed from CA 2199989 external-priority patent/CA2199989A1/fr

1998-03-13 Application filed by Transgene SA filed Critical Transgene SA

1998-03-13 Priority to CA 2229515 priority Critical patent/CA2229515A1/fr

1998-09-13 Publication of CA2229515A1 publication Critical patent/CA2229515A1/fr

Status Abandoned legal-status Critical Current

Links

230000014509 gene expression Effects 0.000 title claims abstract description 52
241000714192 Human spumaretrovirus Species 0.000 title claims description 73
108010003533 Viral Envelope Proteins Proteins 0.000 title claims description 7
108090000623 proteins and genes Proteins 0.000 claims abstract description 107
101710091045 Envelope protein Proteins 0.000 claims abstract description 103
101710188315 Protein X Proteins 0.000 claims abstract description 103
239000002245 particle Substances 0.000 claims abstract description 88
102000004169 proteins and genes Human genes 0.000 claims abstract description 71
230000003612 virological effect Effects 0.000 claims abstract description 50
238000000034 method Methods 0.000 claims abstract description 17
238000004519 manufacturing process Methods 0.000 claims abstract description 9
201000010099 disease Diseases 0.000 claims abstract description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 4
102100021696 Syncytin-1 Human genes 0.000 claims abstract 21
210000004027 cell Anatomy 0.000 claims description 123
230000001086 cytosolic effect Effects 0.000 claims description 56
239000013598 vector Substances 0.000 claims description 38
230000001177 retroviral effect Effects 0.000 claims description 37
241000700605 Viruses Species 0.000 claims description 24
230000004927 fusion Effects 0.000 claims description 24
238000003776 cleavage reaction Methods 0.000 claims description 18
230000007017 scission Effects 0.000 claims description 18
241000713673 Human foamy virus Species 0.000 claims description 17
230000035772 mutation Effects 0.000 claims description 13
108020001507 fusion proteins Proteins 0.000 claims description 11
102000037865 fusion proteins Human genes 0.000 claims description 11
238000012986 modification Methods 0.000 claims description 6
230000004048 modification Effects 0.000 claims description 6
108700004029 pol Genes Proteins 0.000 claims description 4
238000002360 preparation method Methods 0.000 claims description 4
238000004113 cell culture Methods 0.000 claims description 3
101150088264 pol gene Proteins 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 2
108700004026 gag Genes Proteins 0.000 claims description 2
210000004962 mammalian cell Anatomy 0.000 claims 3
101150098622 gag gene Proteins 0.000 claims 1
102100034349 Integrase Human genes 0.000 description 88
241000714177 Murine leukemia virus Species 0.000 description 61
241000713311 Simian immunodeficiency virus Species 0.000 description 55
108700004025 env Genes Proteins 0.000 description 31
210000005220 cytoplasmic tail Anatomy 0.000 description 25
150000001413 amino acids Chemical class 0.000 description 20
239000013612 plasmid Substances 0.000 description 20
102100034353 Integrase Human genes 0.000 description 18
108010078428 env Gene Products Proteins 0.000 description 18
101150030339 env gene Proteins 0.000 description 18
239000006228 supernatant Substances 0.000 description 13
108020004414 DNA Proteins 0.000 description 12
208000015181 infectious disease Diseases 0.000 description 11
210000002966 serum Anatomy 0.000 description 11
238000012546 transfer Methods 0.000 description 10
238000010348 incorporation Methods 0.000 description 9
108020004707 nucleic acids Proteins 0.000 description 9
102000039446 nucleic acids Human genes 0.000 description 9
150000007523 nucleic acids Chemical class 0.000 description 9
108010043121 Green Fluorescent Proteins Proteins 0.000 description 8
102000004144 Green Fluorescent Proteins Human genes 0.000 description 8
241001529936 Murinae Species 0.000 description 8
108020005067 RNA Splice Sites Proteins 0.000 description 8
238000001890 transfection Methods 0.000 description 8
241001430294 unidentified retrovirus Species 0.000 description 8
239000005090 green fluorescent protein Substances 0.000 description 7
230000014759 maintenance of location Effects 0.000 description 7
108020004999 messenger RNA Proteins 0.000 description 7
239000002243 precursor Substances 0.000 description 7
238000010361 transduction Methods 0.000 description 7
230000026683 transduction Effects 0.000 description 7
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 6
230000000692 anti-sense effect Effects 0.000 description 6
108090000765 processed proteins & peptides Proteins 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
101710177291 Gag polyprotein Proteins 0.000 description 5
101710125418 Major capsid protein Proteins 0.000 description 5
108091034117 Oligonucleotide Proteins 0.000 description 5
108700026244 Open Reading Frames Proteins 0.000 description 5
238000012217 deletion Methods 0.000 description 5
230000037430 deletion Effects 0.000 description 5
230000000694 effects Effects 0.000 description 5
239000002609 medium Substances 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
125000003729 nucleotide group Chemical group 0.000 description 5
229920001184 polypeptide Polymers 0.000 description 5
102000004196 processed proteins & peptides Human genes 0.000 description 5
230000009467 reduction Effects 0.000 description 5
108020004705 Codon Proteins 0.000 description 4
241000282560 Macaca mulatta Species 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
210000004899 c-terminal region Anatomy 0.000 description 4
230000001413 cellular effect Effects 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
210000005260 human cell Anatomy 0.000 description 4
239000012133 immunoprecipitate Substances 0.000 description 4
230000002779 inactivation Effects 0.000 description 4
208000032839 leukemia Diseases 0.000 description 4
239000000203 mixture Substances 0.000 description 4
238000006386 neutralization reaction Methods 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
230000001566 pro-viral effect Effects 0.000 description 4
239000000047 product Substances 0.000 description 4
238000003146 transient transfection Methods 0.000 description 4
239000013603 viral vector Substances 0.000 description 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
241000282693 Cercopithecidae Species 0.000 description 3
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
108090000288 Glycoproteins Proteins 0.000 description 3
102000003886 Glycoproteins Human genes 0.000 description 3
229920000209 Hexadimethrine bromide Polymers 0.000 description 3
241000725303 Human immunodeficiency virus Species 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
239000004365 Protease Substances 0.000 description 3
241000711975 Vesicular stomatitis virus Species 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
230000006378 damage Effects 0.000 description 3
238000013461 design Methods 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
239000012528 membrane Substances 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
108010089520 pol Gene Products Proteins 0.000 description 3
230000003362 replicative effect Effects 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
241000714188 Friend murine leukemia virus Species 0.000 description 2
101100279830 Friend murine leukemia virus env gene Proteins 0.000 description 2
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
229930182566 Gentamicin Natural products 0.000 description 2
206010061598 Immunodeficiency Diseases 0.000 description 2
208000029462 Immunodeficiency disease Diseases 0.000 description 2
150000008575 L-amino acids Chemical class 0.000 description 2
241000713869 Moloney murine leukemia virus Species 0.000 description 2
108010077850 Nuclear Localization Signals Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
241000282577 Pan troglodytes Species 0.000 description 2
241000286209 Phasianidae Species 0.000 description 2
241000288906 Primates Species 0.000 description 2
101800001693 R-peptide Proteins 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
108020004440 Thymidine kinase Proteins 0.000 description 2
230000003321 amplification Effects 0.000 description 2
-1 bell Proteins 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000007910 cell fusion Effects 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000012634 fragment Substances 0.000 description 2
210000003958 hematopoietic stem cell Anatomy 0.000 description 2
210000003494 hepatocyte Anatomy 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
230000007813 immunodeficiency Effects 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
230000037361 pathway Effects 0.000 description 2
239000008188 pellet Substances 0.000 description 2
238000011533 pre-incubation Methods 0.000 description 2
RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000007787 solid Substances 0.000 description 2
208000003265 stomatitis Diseases 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
238000013518 transcription Methods 0.000 description 2
230000035897 transcription Effects 0.000 description 2
108700001624 vesicular stomatitis virus G Proteins 0.000 description 2
230000007502 viral entry Effects 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
229940088872 Apoptosis inhibitor Drugs 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241001213911 Avian retroviruses Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
101150008012 Bcl2l1 gene Proteins 0.000 description 1
108010039209 Blood Coagulation Factors Proteins 0.000 description 1
102000015081 Blood Coagulation Factors Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
102100026735 Coagulation factor VIII Human genes 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
101710189136 Envelope fusion protein Proteins 0.000 description 1
101710121417 Envelope glycoprotein Proteins 0.000 description 1
101000658547 Escherichia coli (strain K12) Type I restriction enzyme EcoKI endonuclease subunit Proteins 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
241000282324 Felis Species 0.000 description 1
102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
108091006027 G proteins Proteins 0.000 description 1
101150066002 GFP gene Proteins 0.000 description 1
102000030782 GTP binding Human genes 0.000 description 1
108091000058 GTP-Binding Proteins 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
241000713813 Gibbon ape leukemia virus Species 0.000 description 1
241000282575 Gorilla Species 0.000 description 1
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
101001054266 Homo sapiens Delta and Notch-like epidermal growth factor-related receptor Proteins 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
101100058237 Human spumaretrovirus bel3 gene Proteins 0.000 description 1
241000282620 Hylobates sp. Species 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
102100034256 Mucin-1 Human genes 0.000 description 1
108010008707 Mucin-1 Proteins 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
YFONKFDEZLYQDH-OPQQBVKSSA-N N-[(1R,2S)-2,6-dimethyindan-1-yl]-6-[(1R)-1-fluoroethyl]-1,3,5-triazine-2,4-diamine Chemical compound C[C@@H](F)C1=NC(N)=NC(N[C@H]2C3=CC(C)=CC=C3C[C@@H]2C)=N1 YFONKFDEZLYQDH-OPQQBVKSSA-N 0.000 description 1
241001045988 Neogene Species 0.000 description 1
241000772415 Neovison vison Species 0.000 description 1
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102000007327 Protamines Human genes 0.000 description 1
108010007568 Protamines Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
241001492409 Retro-transcribing viruses Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
101710167605 Spike glycoprotein Proteins 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
206010042566 Superinfection Diseases 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
108010046722 Thrombospondin 1 Proteins 0.000 description 1
102100036034 Thrombospondin-1 Human genes 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000002259 anti human immunodeficiency virus agent Substances 0.000 description 1
239000000158 apoptosis inhibitor Substances 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
101150077466 bel gene Proteins 0.000 description 1
101150022111 bel2 gene Proteins 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000003114 blood coagulation factor Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000034303 cell budding Effects 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
229940030156 cell vaccine Drugs 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
238000001514 detection method Methods 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
230000006870 function Effects 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000004524 haematopoietic cell Anatomy 0.000 description 1
230000002440 hepatic effect Effects 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000006801 homologous recombination Effects 0.000 description 1
238000002744 homologous recombination Methods 0.000 description 1
108700005872 human Fv Proteins 0.000 description 1
102000056549 human Fv Human genes 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000002637 immunotoxin Effects 0.000 description 1
231100000608 immunotoxin Toxicity 0.000 description 1
238000011534 incubation Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000013383 initial experiment Methods 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
230000010189 intracellular transport Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
230000002601 intratumoral effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000035800 maturation Effects 0.000 description 1
230000034217 membrane fusion Effects 0.000 description 1
238000012737 microarray-based gene expression Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000012243 multiplex automated genomic engineering Methods 0.000 description 1
101150091879 neo gene Proteins 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
230000025308 nuclear transport Effects 0.000 description 1
230000030648 nucleus localization Effects 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
229950008679 protamine sulfate Drugs 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
229950010131 puromycin Drugs 0.000 description 1
238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
238000012216 screening Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
238000004448 titration Methods 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
238000005199 ultracentrifugation Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000001262 western blot Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
- C12N2740/17022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
- C12N2740/17023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
- C12N2740/17051—Methods of production or purification of viral material
- C12N2740/17052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA 2229515 1997-03-13 1998-03-13 Expression d'une proteine de coque de spumavirus Abandoned CA2229515A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA 2229515 CA2229515A1 (fr)	1997-03-13	1998-03-13	Expression d'une proteine de coque de spumavirus

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CA2,199,989		1997-03-13
CA 2199989 CA2199989A1 (fr)	1997-03-13	1997-03-13	Expression d'une proteine d'enveloppe de virus spumeux
CA 2229515 CA2229515A1 (fr)	1997-03-13	1998-03-13	Expression d'une proteine de coque de spumavirus

Publications (1)

Publication Number	Publication Date
CA2229515A1 true CA2229515A1 (fr)	1998-09-13

Family

ID=25679126

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2229515 Abandoned CA2229515A1 (fr)	1997-03-13	1998-03-13	Expression d'une proteine de coque de spumavirus

Country Status (1)

Country	Link
CA (1)	CA2229515A1 (fr)

1998
- 1998-03-13 CA CA 2229515 patent/CA2229515A1/fr not_active Abandoned

Publication	Publication Date	Title
Lindemann et al.	1997	Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins
JP5760023B2 (ja)	2015-08-05	安全性の改善された発現ベクター
US9090908B2 (en)	2015-07-28	Chimeric glycoproteins and pseudotyped lentiviral vectors
AU671101B2 (en)	1996-08-15	Defective packaging non-oncoviral vectors based on MPMV
US6448390B1 (en)	2002-09-10	Stable envelope proteins for retroviral, viral and liposome vectors and use in gene drug therapy
US6277601B1 (en)	2001-08-21	Expression of a foamy virus envelope protein
US5929222A (en)	1999-07-27	Expression of a foamy virus envelope protein
US6132731A (en)	2000-10-17	Murine leukemia virus vectors
WO1998047916A1 (fr)	1998-10-29	Polypeptides bifonctionnels utilises dans le ciblage viral specifique en fonction des cellules
AU733948B2 (en)	2001-05-31	Expression of a modified foamy virus envelope protein
US6762031B2 (en)	2004-07-13	Targeting viral vectors to specific cells
US6274722B1 (en)	2001-08-14	Expression of a foamy virus envelope protein
US6703226B1 (en)	2004-03-09	Expression of a foamy virus envelope protein
CA2229515A1 (fr)	1998-09-13	Expression d'une proteine de coque de spumavirus
IL116216A (en)	2007-02-11	Eukaryotic cell lineages for recombinant viral retroviral RNA storage, using trans-expression vectors used to complete the trans
Stitz et al.	2001	MLV-derived retroviral pseudotype vectors
HK1073479B (en)	2009-07-24	Improved chimeric glycoproteins and pseudotyped lentiviral vectors

Legal Events

Date	Code	Title	Description
2003-03-04	EEER	Examination request
2008-03-13	FZDE	Dead